RFP 2025.14 End-of-Project evaluation for Unitaid’s investment on “Better tools for diagnosis and treatment of Plasmodium vivax malaria” Project (VivAction). (Албания - Тендер #67453172)

Description

RFP 2025.14 End-of-Project evaluation for Unitaid’s investment on “Better tools for diagnosis and treatment of Plasmodium vivax malaria” Project (VivAction). In order to access the Request for Proposal (RFP) documents, please log-in as a registered Supplier (Account registration accessible on https://www.ungm.org/Account/Registration). If any Bidders experience difficulties in accessing the RFP documents after having registered and expressed interest, please send an email to: unitaid-rfp@who.int Objective of the consultancy: To identify a suitable provider with relevant experience to conduct end-of-project evaluation for Unitaid’s investment on “Better tools for diagnosis and treatment of Plasmodium vivax malaria” Project (VivAction). Qualification of Firm and Consultants: Bidder shall propose a multi-disciplinary team of 3-4 experienced evaluators, including the team leader. The team leader must have at least 10 years of strong experience leading evaluations of a similar scope and complexity and ideally a strong understanding of market dynamics and interventions to increase access to testing in low and middle-income countries. Core team members should have at least 5 years of individual experience in their respective areas of technical expertise. The proposed evaluation team should meet the following requirements: 1. Expert knowledge of the malaria field and the challenges related to malaria in LMICs, both community-level, referrals, and different levels of health facilities as it relates to malaria management. 2. Strong experience in conducting evaluations of grants in the field of malaria policy and guideline revisions both normative and in-country. 3. Strong experience in conducting evaluations of grants using the OECD DAC criteria. 4. Demonstrated strong knowledge of the challenges and options around ensuring access to innovative health products in LMICs in countries where p. vivax is endemic. 5. At least one team member with strong expertise in malaria treatment in p. vivax. 6. At least one team member with strong expertise in collection and analysis of qualitative data. 7. At least one team member with strong expertise in quantitative assessment of public health and economic impact. 8. Expert knowledge of the global health landscape and the dynamics of introducing and scaling up interventions for complex health issues, including new treatment, at national and global levels. 9. Fluency in English is required, and at least one team member should be proficient in Spanish and Indonesian language for country assessments. 10. Consideration for appropriate representation with regards to gender and a broad mix of backgrounds, skills and perspectives is desirable. Bidders are invited to submit a proposal for the above mentioned RFP in accordance to the documents attached in the "Tender Document" tab. Proposals must be submitted via UNGM, through the “RFP documents” tab and upload documents in “My Tender Return” no later than 17:00 hours Geneva time on 22 October 2025. Given the time constraints and hard deadlines, extension of tender closing date is not feasible. Bidders are encouraged to plan and submit the proposals by this closing date.